I'm Rick You've posted each time Twitter more juicy content. Thank you to Everybody who supports on patreon follows on the official Twitter account subscribe and hit the like button. Please do please do Just true just true just pity just true just true It's anybody ever you're trying to screw me anybody ever as anybody ever opened you up with a wine bottle opener Actually, yes, that's that's an easy way to open me up You just use that on some wine and I will very quickly be is that your kink Well depends on the size of the wine bottle today We got a these are ads. Oh great. And but this is a Moonabye in circuit are back I think they actually get them. Yes. Oh And this is a Sanjay and then Arshad Arshad Warsi You did like a couple ads for whatever some company as Moonabye and circuit. That's awesome And so that's awesome as long as the writer and director are okay with that because there's some things that have happened example There was somebody who was trying to get Robert De Niro to do his you talking to me line from taxi driver for a car insurance commercial The writer of taxi driver found out that this was in the rumor mill and publicly I think tweeted it and said Please no Please don't do that I don't I don't think I don't think he could stop him though Couldn't but yeah, he doesn't want that iconic character in that iconic line Remembered more for a car insurance commercial than the film I don't think anybody's gonna remember more for the car. Oh, that's why I don't like jingles being other people's songs write your own jingle What do you mean? When people take a song and they use the song as their ad for their product Rather than write their own jingle for it happens a lot where where somebody uses John Lennon specifically said that will never happen to a Beatles song you never wanted it to but he doesn't have any power over that anymore because Sony owns the catalog and he's dead. Yeah, but Sony owns a catalog None of the power cuz he none of the Beatles Paul McCartney owned the catalog for a while and then more and then Michael bought it and then Sony got it. Wonder how they got it Anyway, so anyway, I just wondering if this was if the person who created these characters is really happy about it Or he's growing. Well, that would be Rushmore Hirani Okay, thanks, so he's probably fine with it. Here we go I I thought that like the concept works very well actually for for health insurance it does obviously that was his whole thing in in monobuy was taking on the health care system yeah and they I wonder how difficult if at all it is for them to slip into those characters I bet it's like riding a bike easy yeah probably just fun riding the bike how many characters could you could you do with Fagan like slip into it immediately immediately yeah pretty much every character I've ever done I can just drop into pretty quick yeah yeah um yeah because they're just they're right there as long as the character's been under your skin it's probably it's like watching Johnny that beat cap and jack at the drop of a hat he's just he's there that's just there and I'm sure he could do the same with Edward scissor hands he could do the same with Wonka yeah exactly um it makes it like I feel like you should make a third film yeah make a third monobuy film um in my because like the the first one was it was just his first film it's great but then the other one the second one was just a few years after right yeah so and that was what 2008 that I don't remember I don't remember the year far back yeah right um so we need them we need them to come to the states to fix the health health care system here in America it was 2003 was the first film oh wow 20 years ago and so the second one was 2006 wow so what are moona by in circuit doing what are they doing now 20 years later send them to America to fix our health care system I don't think they would do that because literally they can't fix it they could no they couldn't unless they literally are in congress can can pay people yeah no congress can't change it why would congress change it oh congress could change it they won't yeah there's a difference that's what I meant by they can't yeah yeah yeah no no they could well they could they won't yeah no we need to just watch these two guys take on the medical industrial complex that's what I'm talking about yeah just just and the second one obviously had a similar kind of like that but it was a lot more religious uh parts of it that well I think a lot of Indians connected with it a lot more than what we could have because it had a lot more religious yeah um Gandhi I'm interested take a peek at Raj Kamaharani's page is is there anything maybe in just development for a third no moona by no one he has announced he's I think he's gonna wait for donkey to come out oh Amir Khan though interesting an untitled collaboration with Amir Khan that's all it says and that's the only attached person that's great though having that's nice to know Amir Khan back in a Raj Kamaharani that's nice to know he's done two with him right uh yes PK PK and three idiots and it's three idiots yeah yeah yeah uh two that makes me very happy two of the most iconic Indian films of all three idiots might be the most iconic that's the first and one we ever saw at minimum it might be in the top five most iconic and in terms of like recognition yeah everybody's seen it and I think it's probably at the top of the list for anyone who knows someone's never seen Indian cinema to say okay here watch three idiots yeah yeah it's it would be for me three idiots would be in there Sholay would be in there in as far as classic Indian and I guess this would just technically be you know you could you could include in all Indian cinema but Hindi specifically yeah yeah um three idiots it's a perfect combination I think for introducing somebody because it has some of the old school 90s feel with the comedy and the musical numbers but then it also goes into really deep social issues that surprise you that it got so heavy so it's just a great movie doing the list here of most iconic let's just put it in Hindi just to make it slightly easier well iconic I think it had to be three idiots is there DDLJ DDLJ is definitely there Sholay I think would probably be in there I absolutely the ones we've seen obviously we'll miss a bunch but yes like the most iconic this is you've got to put these in a time capsule and preserve them forever you need to watch these to know Indian cinema in terms of all Indian cinema I'd probably put RR in there now just because of what it's meant of course worldwide I think also most would say and I think you'd agree that K3G should be part of that inclusion I was because I was just talking about this in a what would you think about Virzara no wouldn't no I don't think in for also maybe I'm thinking we should ask this differently oh iconic is so different Mr. India mother India mother India maybe it did win I mean got nominated for an Oscar because uh my Lagann Lagann I think would be in there in my film club we just did naked gun and we were for some reason also talking about what are the most important comedies of all time what influenced everything else one of them I think somebody actually thought a naked gun would be in because of what it influenced after that I think it would be more airplane you don't have a naked gun with an airplane and then you could also include stuff with blazing saddles yeah more recently I think the most important past 2000 is Anchorman yeah I think it's influenced everything it really has after uh whenever I think it would came out in 2000 another one that really gets lost because this thought of more as a as a as a holiday film I think of it as a holiday film on a comedy elf yeah for sure uh so like if in if you're talking about the most important hindi cinema of all time importance mother India's what what has influenced everything else right after it right three dates for sure is in there I think Sholey is definitely DDLJ a thousand do you include dongle because of the box office no okay I don't either uh I love dongle but I don't that would be a different category obviously agreed I think in terms of what has influenced after it triple r you uh well that like is hindi though oh hindi okay because if you did if you did all of Indian cinema I think Bahubali would actually be in there oh I agree for what it's done you don't have you don't have rrr without Bahubali what it's done I agree after it came out in terms of important but if you I'd love to watch Bahubali again if you're just talking about hindi cinema Sholey three dates DDLJ I think we're gone I can't this is pure bias subjectivity and I doubt anyone would agree with me necessarily for me it's because of what it did and it birthed this channel gully boy yeah I don't think anybody else would agree but I understand why you're saying that for sure um it because like and I'm also trying to think of like Sanjay Bansali but also I don't know if that influence everything else what was the what kind of influenced did lunchbox have in that regard because I would include lunchbox as far as important films that need to stay on a time capsule I don't know how much it influenced yeah everything else and you probably have to go back to maybe Dilip films Dilip Kumar films in terms of like back in the day what's the film where Shahrukh Khan kissed somebody it's uh we haven't seen it yeah I know we haven't seen it but that is a turning point in Indian cinema why because Shahrukh Khan kissed someone now I don't think that would be including an importance because one I don't know that the film did too well and also a lot of Indians just thought it was weird that Shahrukh Khan was kissing people but it also was a statement of this is acceptable because if Shahrukh Khan does it I think I would probably include maybe Devdas could be in there because but probably the original Devdas um Mughal is um I know it didn't do box office but how do you not include gangs of wasiper that's true I just but like I said it's just a different question because if we're talking about importance right I think it's so important I do I do as well I think it'd be up there but whether it'd be in the top five with DDLJ Lagan Sholei um what was the other three idiots uh K3G probably I really do think gangs is I probably put the gangs in the top 10 yeah I think I'm talking like gangs is groundbreaking how many films after that did it influence that's true yes on your and I think it'll be more top 10 than top five though yeah because then it's just a more niche genre as opposed to what did K3G do everybody made romance of course but I I think I see I'd love to talk to Indian film historians about the impact that gangs had not just on Indian Hindi cinema and Indian cinema but how yeah how it paved the way as a template for what could be done not just for theatrical releases but what gave everybody permission to do and emulate for OTT yeah maybe um um yeah in terms of iconic characters though Moonabai was probably Moonabai's uh yeah you talk about because that's a thing you have some films that maybe they weren't spectacular but the characters within them I mean Magumbo that's the first one that comes to mind I don't know what shower conformance you'd include but probably DDOJ in terms of like it's just iconic character yeah because all the other characters come after that um uh Magumbo would definitely be in there 100 percent Magumbo's in there say I used to go bar more iconic than um I'm gonna talk about John's character in in Charlie he might be might be um the angry young man just as a whole it's um but because you have to include one of those in there because he influenced and we're just talking Hindi right now right yeah yeah yeah yeah that's just like iconic most iconic characters yeah I think just because you can't include not include any Amitabh Bachchan characters because he influenced everything with that whole time period well and what would Salman Khan fans say is Tiger I mean what the impact that was way later in his career though yeah but what impact does that does does he have on on action now in Indian cinema I mean he created a whole universe so for sure um but he was also more known for his romance just like Shabra Khan was in in the early 90s and then there's just the technical aspects of the groundbreaking beauty where do you start with someone's contributions like a Sanjay Leela Bansali yeah yeah it's a it's a difficult question I think everybody would have a different answer they would uh and I'm sure the stuff we're not bringing up that stupid babies would mention and we'd say oh yeah for sure say yeah you're right I forgot or we haven't seen it yet what would you think for Hindi cinema are the top five most iconic not iconic important films industry changes of culture changing when it came out it changed everything yeah what would your top five be I'd love to ask that I'd love to I hope I can remember that it's a great question for interviews it's something I'd like if we were talking to Karan Johar or Hindi yeah or Shahrukh Khan and not just their own films but of all time obviously with those too many you could easily point out to films that they've done but like talk to taboo what does she think what does Vishal Bardwash consider to be what does Anurag consider to be what does what does a Radhika Abdei consider to be yeah that's a good question right anyway that was a good ad so yeah we've been off right now here uh let us know what you think about it down below


Danger, Dr. Danfield. Mr. James Smith, will you please rise? Yes, Your Honor. Before I pass sentence, have you anything more to say? Anything in your own defense? Only one thing, Your Honor. I'm in it. The facts speak differently, Mr. Smith. The evidence against you is overwhelming. The evidence given at this trial conclusively proves that you shot your partner down in cold blood with full and complete deliberation, premeditation, and malice support. I, therefore, by the powers vested in me by the Constitution of the United States of America, sentence you to be hanged by the neck until you are dead. May God have mercy on your soul. But I'm innocent, I tell you. Innocent! Innocent! Dr. Daniel Danfield, student of crime psychology, has, many times, provided the police with a solution to a baffling crime. As usual, there's an interesting case for the doctor today. We'll call it, Mad Men Strikes Swiftly. Brest and I were glad to come down, Warden. What's on your mind? It's about James Smith. He's due to be hanged at six o'clock tomorrow morning. James Smith? Yeah, Smith? I don't believe I remember the case. Do you arrest him? Me neither. Well, you know more about the fear in these cases. But I don't know about this one. I don't know. Well, just the fact that you have your doubts, Warden, is very interesting. Come on, please tell me more. Well, I have nothing to go on except a hunch. My mind tells me that Smith is guilty of the devil. The evidence against him was almost indisputable. Well, then what does cause you to believe he might be innocent? Well, in the first place, he has continually protested his innocence. Oh? And in the second place, I've gotten to know Smith very well during his six months stay here.  I'll never believe it. I see. Just what is it you want me to do, Warden? I want you to talk to him.  You say he's due to be hanged tomorrow? Yes, at six a.m. Well, come on, then. We didn't very much time. Right away. But, uh, you'll have to stay here. Women aren't allowed in a cell box. Okay. I'll wait here in the office and look at the pictures. And give me a chance to catch up on who's who and crime. Smith's cell is down at the end of the corridor, Dr. Manfield. Uh, is there anything else you want to tell me about the case before I talk to him, Warden? No, I'll let him tell you himself. Yes, yes, that will give me a better chance to determine the truth of the statement. Oh, yeah. Right here. Good morning, James. Good morning, Warden. I've brought somebody to talk to you. This is Dr. Danfield. A doctor? Well, I'm not the old... Uh, Dr. Danfield is a psychologist. We're coming in, Smith. Well, I'm not crazy, Dr. I'm perfectly sane. Trying to claim insanity won't give me a bit of good. Quite true, quite true, Mr. Smith. No, I just want to talk to you. Well, I'm glad to have a chance to talk. It's very little time we're talking left for me, you know. I know, Mr. Smith. Is there anything that you'd care to say? Only that I'm innocent, Dr. Danfield. I see. Mr. Smith, I'd like to have you tell me the whole story in your own words. Start right at the beginning. But I've told it so often. Yes, yes, I know you have, but I haven't heard it. Please, Mr. Smith, do as I ask. I shouldn't interrupt you. Well, if you will. It all started when my partner, Felix Hammond, have scondered with $50,000 of the firm's fund. This was a little over three years ago. Police searched for him in every state, but no trace of Felix has ever found. Naturally, the theft of his size completely wrecked the company. Creditors couldn't be paid, and I went down with the company. I couldn't start over again, nor would he trust me. About a year ago, my wife left me. She's a frivolous woman, extremely extravagant. She likes nothing better than the bed on the horse. Of course, I was no longer in a position to satisfy her whim. A great hate was building up inside me. Slowly at first, but growing, ever growing. I fancied myself a martyr to my partner's property. I swore if I ever so much as laid eyes on him, I'd kill him. And with his little compunction as I'd step on an ant, I even bought myself a gun for that purpose and kept it handy in my dresser drawer. Then on the day of Felix Hammond's murder, I received a phone call. I picked up the receiver. Hello? Yes, this is James Smith speaking. What then? Say that again. Yes, huh? Room 218 Burton Hotel. Yes, yes, I almost certainly be there. Who is there speaking? Well, who are you? I slowly hung up the phone. I just received word that Felix Hammond was living in room 218 at the Burton Hotel. I walked to my dresser and opened the drawer. The gun was gone. What had happened to it or where I missed later, I don't know. But it didn't make any difference.  I'd use my bare hands if necessary. Yes, that might even be better to feel his life ebbing through my own ten fingers. Now I got to the Burton Hotel, I don't remember. I walked there yet, it wasn't very far from my room. All this time my rage was building up inside. At last I'd have revenge on the man who'd wronged me so fearfully. Several people, friends of mine who'd worked for me in my company justified it to trial, they'd pass me in the street and I walked along like a man in a gaze. I don't remember. I do remember walking into the hotel. It was a cheap, dingy place. There was a woman sitting behind the desk. Is this the Hammond Inn? Felix Hammond? Hammond Inn, got no Hammond living here. I mean the man in 218. Oh, that's Mr. Harland. That's of course, he'd change his name. Yes, that's the man, I had his name a little wrong. Yeah, he's in. Always, he never goes out. Thanks, I'll go right up. I started climbing the stairs. And with each step of my rage mounted all the suffering I'd endured during the past two and a half years seized and boiled within me like a molten lava of a live volcano. But I'd release it. I'd release it the moment I put my two strong hands around Felix Hammond's filthy neck. I reached the top of the stairs and walked down the hall. I glanced at the tarnished room numbers. The even numbers were on my right. 212. It seemed to recall a window being raised way off somewhere, I don't know. It made me in my imagination. I stood stoned for a moment. Someone else done what I'd come to do. Had Felix himself cheated me again by taking his own life? Was I being deprived of my revenge? I reached out and tried the door. It was unlocked. I flung it open and rushed into the room. Felix Hammond was lying on the floor.  It wasn't very pretty. And there was a bullet hole. A single, tiny bullet hole directly in the center of his forehead. Mr. Smith, you said there was just one bullet hole? Yes, there was only one shot. And Hammond was bound, hand and foot? Yes. All right, go on. What happened next? Well, there was a gun lying beside the body. I reached down and picked it up. It was my gun, Dr. Danfield, the one I usually kept in my dresser drawer. I see. And tell me, what were your reactions, Mr. Smith? Your thoughts as you stood there down at the dead body of your enemy? Well, it's a strange thing, Dr. Danfield.  I realized that in spite of my overpowering rage, it wasn't in me to kill a man. I was still standing over him, holding my own gun when the police came. I never had a chance. But I didn't do it, Dr. Anthony. I didn't do it. I didn't. I didn't. I didn't. In a moment, we'll return for the second act of Danger, Dr. Danfield. But first, and all back to Michael Dunn for the second act of Danger, Dr. Danfield. I didn't really expect to find an enemy in Smith's room, Dan. There's been lots of forsaking him ever since his arrest. Yes, I know. That's why I may find something, something that the police overlooked. You believe Smith is innocent, don't you, Dan? I not only believe it, but I see I know it. Every theory I have points to it. Oh, keep on looking, man. There's nothing in here but some old worn-out spirits. What becomes of this stuff when Mr. Smith is hanged? Everything in this room will go to his air. It's all air. In this case, I believe there's a string. Well, hasn't she divorced? Ah, not yet. I can't find a thing. Hey, hey, I wonder. Busty, doesn't that picture look a little out of line in the air? Oh, sure. Okay, funny about that. Pictures are always getting out of line. That's when they're up as high as that one is. I think I'll take a look at that. It's an old picture straight, man. Okay. What's that? Insurance policy. Dean Smith's insurance. $50,000. Wow, that's a lot of money. I wonder who the beneficiary is. He's just thinking the same thing. Why don't you look? Ah, excuse me. That's a state. What does that mean? His wife, unless he leaves the will, sitting on the line. $50,000. I bet a lot of people would take a chance on burning for $50,000. Yes, indeed. Let's take a run over to his wife's apartment and see what cooks. Mrs. Smith? Mrs. James Smith? Yes. I'm Dr. Daniel Vanfield. This is my secretary, Ms. Fairfax. Yes. Oh, is it, baby? Oh, you have company?  Tell him we don't need any. Tomorrow's a good morning. I want to talk to you about your husband. Husband? Yes, and we're coming in to talk, whether you like it or not. Open the door and let's talk, baby. I don't know you don't. Come on, let's see.  Come on, come on, my love. Hey. Hey, that's better. Hey, close the door. You bet. Hey, what's the big idea of busting into a lady's apartment? You'll find out in just a minute. Well, Mrs. Smith, won't you introduce us to your friend? Huh? Oh, sure. Dr. Daniel will meet my boyfriend, Mara Fenwick. Mara and me are going to get married after tomorrow. Well, you sure are, baby. And while they're going to get married, are you, Mrs. Smith? That's our intention. Apparently, your husband's execution tomorrow doesn't strike any veins of pity in your heart. Why should it? Middy double-crossed all of us. He double-crossed everybody down at the company by not having his partner bonded. So when Hammond went off with the door, what happened? We was all out of job. Oh, then you knew they soon to become late, Mr. Smith. Sure, I knew him. I was a truck driver down at the company. That's where I met Mamie here. Wasn't it, baby? Yeah. Mrs. Smith, did you know that your husband was carrying an insurance policy for $50,000 payable to his estate upon the event of his death? Sure. I knew me and Mara had been keeping up the payments. Yeah. I got me about 200 bucks invested in that hanging tomorrow. And we have to stay here and listen to this. Just a few minutes longer, Rusty. Well, folks, I'm afraid you're going to be very disappointed. You're not going to collect that insurance. What? What's the big idea? The big idea is that Mr. James Smith is not going to die tomorrow. Why, Amy? Because before tomorrow morning, he was going to prove him innocent. Oh, no, you ain't. What's going to stop me? This pistol I got in my hand. Now, Maro, in your vernacular, what's the big idea? The big idea is that nobody's going to lock up that execution tomorrow. You want to see him hang, even if he's innocent? What do I care? The jury said he was guilty in a judge sentencing him to be hung. When I pronounce him dead, Mamie and me is going to collect the insurance. $50,000. And then we're off to the races. Uh-huh. It won't work, Maro. Oh, yes, it will. You and your rent here is going to sit right where you are.  That is, if you sit quiet and you don't make no fuss. Maybe how about putting on a pot of coffee? Yeah, honey. And if we don't choose to sit quietly? That'll be your tough luck. Hmm. Well, let's see, what do you think you've got to do? Well, at the moment, I'm for resting my hands and feet. Yes. Yes, it does seem to be the most sensible thing at the moment. However, maybe it'd be better if I did this. Hey, watch them together. Doctor's got out of his hand. Get it, Rusty? Uh-uh. I have had to get... Hey!  How you wish! This'll take care of you, Mr. Stanley. Hey! Hey! How you wish? What? Need me help, Rusty? Not anymore. Well, that wasn't very ladylike. Mother, I should have been a bluer girl. What do we do with them, Dan? Better turn them up, I guess. We've got lots of other things to do. You think they killed Hammond? Could be. However, Myrel here gave me a couple of good ideas. Okay, Rusty, let's press them up, and you can go and turn off that coffee. In a moment, we'll return with a third act of danger, Dr. Danfield. But first, and now, Michael Dunn for the third act of danger, Dr. Danfield. And now, Rusty, let's stop this phone booth. Oh, well, how many nickels have you got? Four or five, why? Give me. I want to call four men. Four men who are former employees of Smith Company and who the judge said were the only witnesses at the trial. What do you want to call them for? Well, there's an old saying that a murderer always attends the funeral of his victim. Okay, here you are. But you'll have to pay me back. Uh-huh. Talk it up to the font. Hello, Peter Hinton. Look, this is Myrel Fenwick. Yeah, yeah, Myrel Fenwick. Jimmy Smith's one of his boyfriends. Yeah. What do I want? Well, look, I'll tell you. Me and Mamie know what you've done. And that's what I said. Look, I'm talking from Mamie's apartment. We want that you should split with us. 50-50. Otherwise, we go to the cops. Hey. Hey, don't hang up on me. What's the big idea? I'm afraid so, Rusty. We have a minute to lose. I want to get back to Mamie Smith's apartment. Well, slow down. Here we are. Good. Well, what are you going to do? Just sit here? That's the big idea. Hey, look there. Where? A little mostly, man. I was running up the apartment. How stiff. Well, there is he traveling. Come on, Rusty. Let's go. You trying to get in? Uh, would you like to go in, my friend? Hey, here he is. Your name, I'd say so. I'd rather like to believe. Oh, I guess I must have gotten the wrong apartment. I don't think so. You're coming in anyway. Oh, no, I'm not. Damn, look out. People have guns to make. That's true. Boy, are we good today. That makes three down any more to go. Well, this one should have went as a cigar, Rusty. Here, take this key and open the door. Sure, Mike. Yes, I do. Just drop in. Okay. The two lovebirds don't look any too cheerful. No, no. Well, I just won't take the gag job and untie them. I'm not going to give it any more trouble. I'll take the... Uh-uh. Uh-uh. I'll take baby. Okay. You take baby. There, Mel. Yeah. Thank you. Feel any better? What's the big idea? Oh, Mel. Your conversation gets to Monop. Hey, that's Peter Hansen. Good bookie, but down at the company. I had an idea. It would be. How are you doing, Mel? It's fine. It's only baby. Peter wants to fight. What's the big idea? Oh, no, no, no. You two will make a wonderful pair. You can be Monopte together. What's the idea of bringing Hansen here? Peter Hansen, my dear baby, is Felix Hammond's murderer. Who is that to believe? I thought you were going to blame us. How come? Wait a minute, Maro. Peter over here is beginning to yank. What? What's his name? Not Pete. Who? Oh. I'm sorry. I turned off that coffee. I did have my help to wake him up. I'm all right. Good. Good. Come on over. Have a cheer. He's got some manners to discuss. Now, first, let me put you straight, Mamie and Maro. Don't feel too badly because your husband is going to miss the gallows, Mrs. Smith. He wouldn't have gotten any of the insurance money anyway. One aluminum cent. I'd like to know why. Because I've seen your husband's will. And the beneficiary on that policy wasn't you, Mamie. It was Mr. Smith's estate. Well, I'm his estate. I'm all he has. That's why I ever got a divorce. Yes, yes, I know. When his company crashed, James Smith made a will. A will that enforced his estate to pay every single one of his creditors before you got a dime. Hey, baby, I didn't know that. I know you didn't, Maro. But, uh, Peter Hansen here did. What? I said you knew that all the money was being used to pay the creditors. What's that got to do with me? You are the creditors. You mean it? Yes, indeed, Rusty. For the past two and a half years, ever since the company went broke, Peter Hansen has been buying up the claims. Buying them at zero cents on the dollar. Just recently, he'd run them all. How did you find out these things? A few discreet questions in the right places, Hansen. You've also been on the trail of Felix Hammond. And six months ago, you found him. You knew of Smith's terrible hate for Felix, so you set out to mold it to your own end. I hated Felix. You'd listen to me, Felix wouldn't have been able to steal the money in the first place.  You thought you might need it, as your intentions were to blackmail Felix, and, uh, he might offer a few objections. He didn't have a say. Right. So the only thing left for you to do is collect Smith's insurance.  When you heard him at the door, you shot Hammond, dropped his gun by the body, and left through the window, calling the police at the corner drugstore. Right, Mr. Hansen? I'm not admitting anything. You don't have to. You trapped yourself. When I found out that the beneficiary of Smith's insurance was the creditors, the rest was easy. It was easy to find out that someone had been buying up those claims. Who would that naturally be? Someone connected with a defunct company, somebody on the inside. So I ascertained who attended Smith's trial. There were four men, Hansen, all of whom have been formerly employees of Smith and Hammond. And you were among them. I testified for Jimmy. Testified as to the excellence of his character. Yes, yes, but you knew that your testimony wouldn't clear him of a murder charge. Why pick on me? I couldn't have been one of the other three. Because of the phone call you received this afternoon, Hansen. I represented myself as Miro here, a Mamie's boyfriend. I told you I wanted a split. I also phoned the others. But they're not being guilty. Passed it up as the work of a crank. But not you, Mr. Peter Hansen. You fell for it, hook, blind, and sinker. Why? Because of your guilty conscience. You didn't dare refuse to come any more than you could stay away from the trial. Don't reach for your guns. I removed your fangs while I knocked you out. Now I'll call a governor. Yeah, it's been a great day. In a moment we'll return for the conclusion of danger, Dr. Danfield. But first, and I'll back to Michael Dunn for the conclusion of danger, Dr. Danfield. Oh, Dr. Danfield, it's a great thing to be free again. Spring, sunshine, trees, flowers, even the air. I never realized that even a little restaurant like this could be so big. You know you can thank Dan that you're here. Well, thank him no, my child. I can never thank him enough. If ever a man was completely confounded by circumstantial evidence, that man was me. Passed with the sugar, my dear. Two whole spoonfuls that nobody can completely know. Now, how you could ever have believed my wild tales beyond me.  Oh, it wasn't so hard. I know, but I had every intention in the world of killing people. Meditation and all. I can't blame the jury for convicting me. I'd have done the same thing and I'd been in their place. Well, it wasn't you who made the mistake, man. It was the murderer. I knew it couldn't have been you the minute I found out the condition of the body. Well, I don't see how that could have told you anything. He was just dead. No, that's not just dead. He was tied and gagged, remember? And there was only one bullet hole right in the middle of his forehead. Well, I can't think of anything that would make him any deader. Very cute. Well, anyway, that was a thing to prove Mr. Smith's innocence. That's at least to me. Here's where the psychology comes in, Mr. Smith. Yes, men as mad as James Smith was when he went to see his ex-partner. Don't kill that way. For the rage as great as that, Smith would have emptied his gun into Hammond's body. He would never have been satisfied with only one shot. I believe you're right. Also, he would never have wasted the time to knock him out and bind and gag him. That called for coolness and deliberation. And another motive besides just for passionate killing. Well, all I can say is I'll never get mad again. This has been too close a call. From now on, I'll temper my temper. You hear that, Rusty? Well, what's that remark got to do with me? Well, you didn't get that red hair out of a bottle. Or did you?


A lot of credible prominent YouTube critics have already seen and reviewed Ant-Man 3, they got that early access, they got to tell you how the film is. That's good for them. I've been doing this for a long time. Here's my review for Winnie the Pooh, Blood and Honey. Couple housekeeping things before I dive into what is surely going to be the most popular, most talked about film coming out to mass audiences this weekend. One, I will be getting a haircut very soon, maybe the next time you see me as a matter of fact, so that's something to look forward to, that's something exciting. Two, you should probably subscribe to the channel if you haven't. Adam does movies as I post movie content, reviews, rants, whatever, every single week, and then Ant-Man 3 review is coming, probably Friday, as in like two days from this review. So please be excited, please look for that. It's the taste you can see. I don't know what that means, but let's talk about the taste you don't want to see, and that's Winnie the Pooh, Blood and Honey. Due to some legalese mumbo jumbo, this movie was able to be made, trademark expired or something, Disney still retains the rights to these characters based on the beloved book from the 1920s, but there was a period of time where the rights were up in the air to grab and do with, what a filmmaker pleased, and that filmmaker did something. Let me be Billy Crystal Clear with you. This is not really a movie at all. It's an experiment. It's a fun little aside, if you must. The film cost less than $100,000 to make. It was shot in, I believe I read, 10 days.  We'll get the script right afterwards. This movie has no ending. There won't be spoilers outside of the spoiler this sucks, but the movie is so abrupt, so poorly paced, so quickly shat out to capitalize on the property name. It's, I think, an hour and 24 minutes? I don't even think it clocks in at an hour and a half. Now, I'm a stickler when it comes to time. I value my time enough to appreciate when a movie like this doesn't stay for two hours. It knows it's bad. It knows it needs to get in and out, so that's kind of a compliment, but also a negative because you didn't even finish your story. You ran out of budget or something.  Anyway, the acting, it's about, as you can expect, schlocky B-level acting material. Some actresses do okay. The main one's not too bad. She's got some friends, though, that really ham it up. They're in some scary situations. One of them's like, all righty then. I don't want to die. I don't want to die. Well, maybe nine actors total. You have five or six of the friends that go stay at a cabin who are inevitably going to die as this film proceeds. They all look like they were maybe picked up on Instagram or TikTok. That's their acting resume, and yeah, we just kind of flew by the seat of our pants when it came to the filming this stuff. As for the 100-acre friends, we have Winnie the Pooh. We've got Piglet, who honestly looks more like Bebop from the Teenage Mutant Ninja Turtles than he looks like that cute little pig I remember from the cartoon classic. They both wear cheesy, tight masks that don't have a lot of facial features to them. Winnie the Pooh is often bubbling and pulsating with honey out the mouth. That's kind of his thing. And I do appreciate some of the CG bees that fly along with them. They tag along like they're little buddies of his that he can kind of call on command to attack once in a while like he's in a Mortal Kombat game. Get over here! Winnie the Pooh wins. Flawless victory. Brutality. I went with brutality instead of fatality just to let you know I'm up to the current generation of Mortal Kombat games. I'm a gamer. I'm a player. Not in the whatever. Let's dive into the basic premise. We have Christopher Robin. He's growing up. He's not a little boy anymore. He's going off to college. He wants to start a life in a family of his own. So he says goodbye to his critter friends for five years. In that time, chaos ensues. It's bedlam. It's pandemonium. They have no food. They turn on each other. And all that remains is Poo Bear and Piglet. When old C. Money returns with his fiance to see his buddies, these are not the friends he left. These are not the ones he said goodbye to. What he's now looking at are cold-blooded killers. Murders of the highest order.  That's it. The characters don't talk. It's just Piglet and Pooh, which makes me think that they either A, didn't have the rights to all the characters, or B, just didn't have the time and budget to make prosthetic masks for the rest of them. They also clearly didn't have enough story to get to a full hour and a half, so everything is padded a little bit more than it needs to be even. Whether it's an Instagram model in the pool, taking selfies, or just shots of the woods, where they clearly had one day with a kick-ass 4k camera drone, and they used it, dammit. And they know that was the good camera. There are so many kick-ass shots early on of that forest. I was even tricked for a second thinking, man, this has somewhat of a budget. I'm kind of impressed with this. That quickly washes away with the title screen that I myself could make in a half hour in Adobe Premiere. They used the same techniques I was using in amateur films back in the late 90s, early 2000s, with the like overlay half transparency video on top of another video. The font using the preset color burn. I mean, come on, guys. We can do better. Even the words kind of do that fade and fade out, that little f-gossy and blur. How amazing is that? It's a terrible title sequence with some of the most over-the-top music I've ever heard in a film. It's remarkable. It'll be these bad actresses kind of frumping through the woods, and the music's like, but it's just like two shots back and forth. All right, we forgive a bad story. We forgive bad acting. What about the kills? Is it terrifying your level while me over in this department? No. No, they're not horrible either. There are some great practical effects on display. Some of the kills are kind of cool. You do get the pointless nudity early on. Just one time, I believe. It's not great either. Comical though. He like pulls out the shirt and she's like, ah, I'm naked now. They are really abusing that day-to-night filter. I could tell a majority of the night stuff was shot during the day. You have sun pouring in through the windows, and they're trying to cover it up, but there's harsh light hitting these people. I'm like, that's not the moon. That is not the moon out there. Can you have a good time watching this movie? Yeah, but it's unintentional. You're laughing at the movie, not along with it. They should have gone the hotshots route with this. They should have gone the scary movie route, the parody. I know it's pretty much a dead art form now when it comes to cinema, but bring it back with something like this. And I think a lot of it has to do with the copyright issues or the trademarks, whatever. They can't have Winnie the Pooh in his red shirt with his tummy out, that's Disney. So they can't do a lot of the catchphrases like, oh, bother or a silly old bear, but that's kind of the thing people know about Winnie the Pooh. Are the catchphrases, tigger, little piglet, it would have been hilarious? There's so many ways you could have done this movie, but to just go straight schlocky whore with it and play it completely straight man the whole time, that did not work for me and the people I went with. We all sat there like, this movie, what is this? Who is this for? The best thing I can say about it is the title, Winnie the Pooh Blood and Honey. That's fantastic. I love that.  Make the movie like that. Instead, it's just a boring slasher with these two characters thrown in and nothing else playing off of the material at all. I also have to point out one last thing in the story department. There are several scenes pretty early on where we do a flashback or there's kind of like a B plot. They go nowhere. They don't tie in at all. My buddy, Bless, he turned over to me a couple times. He's like, I bet that's the killer or I bet that's that person or this is going to tie in. I turn around and I'm like, it's not that deep. None of that's going to happen at all. This is a poor flashback to set up a premise to get these girls out of the cabin.  It's so bad. It's so poorly done. And again, they just had to pad out this story somehow to get to the carnage, which again, isn't that great and it's not that often. So to spin a Winnie the Pooh catchphrase, don't bother seeing this movie. It's not worth your time. It's definitely not worth your money. I'm sure there's good stuff on the horizon. Let's just wait till this is inevitably shat out on the streaming service in a couple of weeks and maybe entertain it then. Well, there you have it, the most anticipated movie review of the year. Full stop, Winnie the Pooh. Blood and honey, baby. Did you see it? Did you waste your time and money? Let me know in the comments below. Or if you didn't, why you're not going to go out and watch this right away. Day fun. It's a must watch for many people. Like the video if you had a good time and again, I encourage you to subscribe to the channel. Christopher Robin would want it that way. Christopher Robin says, hey, I don't have Pooh Bear anymore. I don't got Piglet. Well, I got Adam Does Movies and you could too. Join him and me. Why am I still ending this? All right, take care.


are in here recent studies have now proven that the oceans cover nearly 71% of our earth used to be a vibrant shade of blue and much of the freshwater was clear enough to drink saltwater and freshwater wildlife flourished in the good quality of the oceans ponds and rivers however to my great sadness that I must report that in this year of 2081 the vast oceans that used to be so intensely blue are now filled with trash and blackened with oil they are nearly unrecognizable on fire the freshwater ecosystems that used to be the home of countless creatures are nearly deprived of all life and microscopic organisms are the only survivors it's shocking how much has changed I can't even believe the stories I've heard about ocean animals why is our ocean like this it's not because of one person or even one country slowly but surely more and more people start littering and more oil spills occur and eventually it ends up like this but for those of you listening in 2020 don't despair yet there's still hope to rescue our planet's water before it becomes too late so what can you do to help keep our oceans lakes and rivers beautiful maybe take a day at a local beach to clean up the trash on the stand or in the water check for waste collecting around your storm drain and clear it off conserve your water usage make sure you alert someone if you smell a gas leak don't pour chemicals or trash into any body of water and remember storm drains are not for trash or unwanted liquids they most likely lead to a nearby body of water lastly vote for government officials who will enforce strong environmental regulations if you follow these tips you will certainly increase the health of the earth's water for future generations such as mine are in out


Hi everybody, Lee Lowell here, smartoptionseller.com. Today is Saturday, October 9, 2021. Hope everyone is doing well. Welcome to another edition of our Saturday synopsis. What we like to do here in these videos is take a look at the charts, we look at the indexes, we look at individual stocks, and I try to show you what I'm seeing out there, where a stock has been, where a stock may be headed in the future. I'm here to try to help you become a smarter and more profitable stock and options trader. We concentrate on trading options in our service, in our website, but we always have to know about the stocks first. That's the most important thing. Having an idea of where a stock may be headed is the best way to engage in an option trade. You can't trade options unless you know where the, what the stock is going to do or not do. All right, so it's very important to understand what stocks are doing. The way that I understand that and the way that I create my trades is by looking at stock charts. That's how I, that's how I figure out what's going on in the market. It's called technical analysis, stock watching, chart reading, whatever you want to call it, technical analysis, that's one way of figuring out where a stock is going, another way is fundamental analysis. That's more about looking at the internals of the company, how are their sales, how are their earnings, what's their dividend payout, like all that kind of good stuff, the underlying details. I like to look at the charts because I like to see where the stock is moving, where a stock's trending. And I'm in the belief that every part of information about a company, even the fundamental analysis parts of the company is all reflected in the charts, okay? So that's all I need pretty much. And so what I want to do is try to help you read charts as well. So we do these Saturday synopsis videos to try to help you figure out different ways to look at a chart, look at patterns, look at technical indicators, moving averages, all that good stuff. So what we like to do here is we look at the indexes first, the S&P 500, the NASDAQ and the Dow, and then we dial it down to individual stocks. So let's just jump right in here. And we always take a look at the S&P 500 first as represented by the SPY, which is the exchange, traded fund, the trades like a stock, gives a good overview of the broad market in general. Now for those of you just tuning in, this is what I use to look at charts. This is my eSignal platform. You can look at charts on many different platforms and some of them are free out there. This one I use called eSignal. I believe it's a pretty good platform and using it for over 20 years now. And on my charts, I usually look at a daily bar chart. Each one of these black vertical lines is one day's worth of trading. I can open it up a little bit more, make it easier to see. And on my real estate here, my screen dials it back to about two years in time of daily chart, of daily trading activity. If you're a hyperactive trader, you can look at one minute charts. And when the screen pulls up here, each one of these bars now is one minute's worth of trading. So a one minute chart is going to look a lot different than a daily chart. We get a lot more history. We wanna see where a stock is trending. Which way it's moving? Is it moving up? Is it moving down? Momentum is a big deal in the market. Because everyone's playing the same stock. Everyone's looking at the same chart formations. So everyone pretty much sees the same thing. And if they're knowledgeable enough, they look at the same indicators, see which way a stock's trending. So momentum is very big in the stock market. And a stock will trend in one direction until something comes along and moves it in another direction. That's typically either a bad earnings announcement, which comes every three months or some other news item within the company or just general market news. Geopolitical news can always move markets. But in the end, it's how well that company is performing is what's going to determine its price trend. If the company is creating good products, people keep buying those products, the company's sales and earnings keep going up over time. A stock will tend to move up in price over time. And on a chart, that's moving from bottom left to top right. That means the stock is moving up. So let's take a look at the general broad market. Now typically individual stocks, if there's nothing really going on with that company, they'll tend to follow which way the indexes go, okay? And if the indexes are moving up, typically a stock will move up as well, even though there's no major news going on with that company. So we like to really focus on the indexes here. Now what you'll see on the chart is, I've got certain things marked up. I've got channels here, W patterns. Down here is the RSI indicator. People ask me, Lee, what do you usually put on your charts? What are the indicators that you use? So I'll go over that briefly, do that each week. I know we have new people watching every week. On the chart, this is a daily open high low bar chart. Some people use candlestick charts. I don't use candlestick charts. I just use the open high low close bar. So each vertical line has a little dash mark on the left. This is where the stock open for the day. The high and low obviously is the top of the bar and the low of the bar is the low of the day. The bottom of the bar is the low of the day. And on the right side of each bar, there's a little dash mark. You can see this one right here. That's where the stock closed for the day. The closing price is very important, okay? And then so I have three moving averages on each chart. I have a blue, simple 20 day moving average. And then I have this red, simple 50 day. And then the green is the simple 200 day moving average, okay? So what I like to do is, first of all, you like to see the general direction of the stock or index obviously moving up since the pandemic last year, March 2020. Stock markets just had been steadily moving higher. Now, what we try to do is in our service, in our newsletter, we're looking for bullish patterns. We want stocks to go up. So we're always trying to time our entry to a good spot. And how do you do that? Well, if a stock's in an uptrend, you wanna try to time your entry when it's on a pullback, okay? Even if you're gonna be holding a stock for a very long time and talking years and years, you know, where you get in really doesn't matter so much in the short run because eventually hopefully the stock will go up over time. But if you're on a shorter timeframe, your timing is a little bit more important. So when you're trying to time an entry, especially a bullish entry, you wanna try to enter on a pullback. Well, how do you know if a stock's on a pullback or how do you know if a stock is entering a new full-on bear move? Well, in the end, you don't, you don't. But you have to go with history. You have to see what a stock's been doing in the past and hopefully that history will keep going. Now, if there's no major news on a company, you know, their earnings aren't coming out for a few months and there's nothing else happening in the background, the stock will typically keep going in that same direction. And when you wanna time it, the way that we do it, we look for pullbacks to either the 20-day or 50-day moving average. Now, you can see on the S&P 500, every time you either pullback to the 20-day or 50-day moving average, it will bounce. Okay, so if you're looking to time your trade, you wanna look for a bounce or a pullback to the 50-day or 20-day moving average. Typically, most of the time, it won't pullback to the 200-day moving average. That would be a pretty good sell-off. So if you're going with what's been happening, if you're trying to time a trade, you can look for a pullback here, you can look for a pullback here. And so every time it goes up and pulls back. So what I try to do is I try to get a gauge for where stock's going and where it might move to next. Now, we had a situation where the general stock market had been going up, up, up, up, up, and then right around September 1st, we've entered into this new pullback. So for the last month, it's about six weeks now, the market has been in a pullback. Okay, something came along and knocked it out of its uptrend. And what was that? Why are we seeing this pullback now all of a sudden? Why wasn't the pullback here or pullback here? I think there's a few things. Number one, we have seasonality in the stock market. In general, in the long run, the three months, the three worst months for the stock market is typically August, September, and part of October. Okay, so we're seeing some seasonality here. It's a little bit deeper pullback than probably the last couple of years that I have to go back in time. But August, September, part of October, you can typically see pullbacks. So I'm not really concerned so much with this pullback. Other news items, COVID's still out there, inflation's creeping up. In the US at least, there's rumblings about the debt ceiling, and the Federal Reserve, that might start taking interest rates higher. So there's a lot of this narrative out there that can spook the market in the short run. But in the end, it's all about how well are the companies within the index is performing? Are they still selling their products? People are still buying, earnings are going up, earnings are going up quarter after quarter. That means the stock prices have to move up. But in the short run, you get these news items seasonality that can take the market down for shorter periods of time. If we go back out to the monthly chart where we can look back to early 1990s, we can see the market just goes up over time. Even though there's news items out there, we had the financial meltdown, there's wars overseas, there's just COVID came along, but we can see how COVID was very short-lived as far as the stock market goes. So you've got these narratives that are always out there, but the stock market will always pick itself back up. So what are we seeing right now? Let me take a quick look here. Now, it was in the uptrend, now it's in the downtrend. And I draw these, they're called channels, they're price channels. When a stock bounces for a long period of time or a period of months, you can draw these trend lines that will help you gauge where a stock may pull back to or hit some resistance. And after like two months or so, you can connect the tops of the recent ranges, connect the bottoms, and you can project out with the lines. And you can see how the stock, this index, the S&P 500 has been bouncing in this uptrend. So if you're trying to time your trades, you can wait for it to bounce off the bottom leg, or if you're looking to sell or get out of positions, you can wait to see if it hits some resistance at the top, and it'll pull back. Apparently now, up on September 1st, it didn't bounce off the bottom and now it's created this new little downtrending channel here. So right now we're in a downtrending channel. If I was to get bullish and wanted to get long, now I have to wait for the market to come outside of this new downtrending channel, maybe trade sideways for a bit and start to move higher. Now we can see the downtrending lines that I've drawn this channel on Thursday and Friday this past week. So that was October 7th and 8th, 2021. The S&P 500 had a nice bounce up from the sell-off has moved outside and above the downtrending channel. You can see it right here. These two days has moved outside of the downtrending channel. That's a good sign, that's something that's good. I like to see that. I need a little more confirmation, maybe another week's worth of trading outside some sideways action and or some upwards movement. So sort of in a hold pattern right now, for me, if I was to look to get long or bullish on the stock market, because we could get another pullback back within the channel, the more days it spends outside of the channel, either sideways or moving higher, the more confident that I would feel that the next leg of the bull market will be starting. Now, typically towards the end of October, November, December are usually pretty bullish times of the year. So I'm hoping that seasonality at the end of the year will get that push higher. Let's take a quick look at the NASDAQ as represented by the QQQ and we'll see what was happening there.  So what we'll do is we'll just, you connect some of the tops of a recent range and you connect the bottom. So now you have this channel here. So the QQQ is represented by the NASDAQ, represented by the QQQ has, is still within the channel. Okay, it hasn't popped out of outside of it. So we may see some resistance here and there's potential for the stock market to keep coming down towards the lower end of this channel. We don't know that yet. Next week, maybe we get some really good news and we'll start to pop out of it and move higher again or it will continue to move lower. So I'm not calling the end of this little sell-off yet. I think we may have some more room to move on the downside. You know, right now I'm treading lightly because once the stocks or markets in a downtrend, there's really no reason to step heavy into getting bullish until the market or the price action tells you to. It's all about the price action, right? We had the nice up move, but now it's telling me it's in a little downtrend. Why get into a bullish position while it's still showing you there's potential for more downside? It'll just frustrate you, you don't wanna do that. So I'm waiting for some confirmation. I'm waiting for the market to pop out of this little downtrending channel and move some sideways action and maybe go higher. Let's take a quick look at the Dow. See what the Dow is doing. I don't pay as much attention to the Dow because it only has 30 stocks in that index. Let's see what's going on. So the Dow is in a little bit of a downtrend, not as much as the S&P 500 or the NASDAQ. We can draw some support lines. Let's, we have the resistance up here. You draw the line, you got a little resistance on the top and then you have, you've got some, maybe some support here. And it's in the eye of the beholder. Not everyone sees the same things. People can draw lines differently. It's not an exact science. It's not an exact science. So we've got this little bit of a channel here. We have the moving averages. So the Dow is sort of trading more sideways than anything right now. All-time highs was here. So we're really not that far off the highs. So the Dow will probably get its cue from the S&P 500 or the NASDAQ. It's kind of moving sideways, not much happening with the Dow. Let's take a quick look at some individual stocks now as we typically do. But to sum up here in the indexes, I'm waiting for a little more confirmation of sideways action or higher. There could be more selling involved at this moment in time until the market tells us otherwise. So let's take a look at some individual stocks. Take a look at Apple. We typically tend to look at the more popular high volume stocks. Okay, so this is Apple. What can we say about Apple? Oh, and I forgot to mention my technical indicator down here is the RSI. It's a 14-day RSI indicator. It's an overbought, oversold indicator. The default is the 75 and 25 levels. It's from zero to 100. 100 would be the most overbought a stock can get. Zero is the most oversold it can get. The default numbers are at 75 and 25. You can see the vertical, the horizontal lines here. I've moved my lines out to the 80 and 20 level to give me even more of an opportunity to see if a stock is overbought or oversold. And it will bounce within that range. It doesn't mean, when it's overbought, it doesn't mean it's going to drop right at that moment in time, it could take a little while. And when it's oversold, it doesn't mean it's going to reverse higher right then and there. It's just giving you an advanced warning that a market's a little overheated or a little oversold, just keep an eye on it. But for now, we're looking at Apple. Here's the price action. Here's some channel that I drew. Head has dropped below the channel. It's still remaining above the 200 day moving average. Apple's kind of, the chart's a little ugly. It's not in a perfect uptrend. You have ups and downs and ups and downs. It's still moving upwards, but not as strong as the general indexes.  You know, try to pop above the channel has fallen back below the channel. It's trading below the 20 day and 50 day moving averages, but still above the 200 day. So Apple will probably meander sideways here for a little bit. The RSI, not completely oversold, but certainly in a downtrend. So Apple, I wouldn't say bullish or bear strongly in either direction right now. It's just kind of moving sideways here. So if you're trying to get in, it might frustrate you a little bit because it doesn't have a lot of follow through so much on either direction. It goes up, it goes down. So Apple, not so interesting for me at the moment. Let's take a look at Tesla. Tesla is still in this, I drew this uptrending channel not that long ago. So it's stuck in this uptrending channel kind of hovering near the highs. It's above all the moving averages, which is good. And you also like to see which way the moving averages are sloping. Right now they're all sloping upwards. That means the stock has good upwards momentum. If the moving averages are sloping downwards, that means the stock is probably moving down as well. So you kind of want to wait for a little bit of a turn before you really engage in a new bullish position. But Tesla's been in this channel. The next possible move will probably maybe come down to the downside a little bit, maybe a little reversal, not too much. It may try to tag the 20 day or 50 day or come all the way down to the uptrending bottom leg of the channel. Hard to say, or it could just keep moving up. But Tesla definitely in an uptrend. So having more of a bullish position is probably a smarter bet than having a bearish position. Tesla's moving upwards. RSI, not really oversold, overbought, just kind of in the middle. So that's not telling us anything either.  Let's take a look at Amazon. And it's all about trying to look at the patterns, look at the channels, see what the stock's doing, where's the trend, where's the price action. That'll help you get into a trade at a better time. So Amazon, and we can always get rid of these lines and make new ones, because the pattern is still playing out here. It's just stuck in this very, very long channel. Okay, it just, it can't really break itself free from, now where you wanna draw the lines, you can connect the extreme bottoms of past moves and try to connect where most of the tops have been. So you can see Amazon popped above the channel, but then it came back in, it had this earnings washout right here. And then it's just kind of been bouncing around, kind of hugging off the moving averages. So Amazon still trading within this wide range. You know, it is very expensive. So there's not much happening either way. Yes, you can maybe do some intraday trading or a couple of weeks, but not much in the long run for me at the moment on Amazon. Let's see what other stocks we have that are worth noting. We look at Oracle, we love Oracle. We have a put sell on Oracle, and Oracle's just in this nice uptrending channel. Had a blast off here yesterday, Friday, October 8th. Let's see, is that's all-time highs for Oracle, yep. So Oracle's making, has made all-time new highs. This is the monthly chart. So here, Oracle's just looking strong. The R-size not overbought yet. So there could be more upside to come on Oracle. You may have a little bit of a pullback because this is a pretty good move here this last week of trading. Has bucked the trend in the overall market. Oracle's strong. We sold put option on Oracle and our service, which we like. So this is working out for us. Oracle, let's take a look at Cisco. Cisco, I like the company as well. Getting close to impossible, put sell position, but it's in this downtrend, okay? It's in the downtrend. So it hasn't told me yet that it's ready to start a new uptrend. You know, the 200-day moving average is the next line in the sand. Moving down in the R-size, so it could be a potential for the next leg higher. I'm watching it for a little bit more. Let's take a quick look at, and I've been talking about Clorox of late, why you would not want to get into a bullish position on a stock until it shows you that it's ready to move up. Now, Clorox was a darling during the pandemic and then last August, it just started in this downtrend, which it's still in now. So trying to pick bottoms, trying to, you know, it's a great company, but why get long on a stock while it's in a downtrend? A lot of people don't watch stock charts. They just know that Clorox is a great company. I'm gonna buy in. I'm gonna buy in now. But eventually maybe you'll be right and the stock will go up, but let's just say you bought here or here. Well, the stock's still going down, even though it's a great company, you're not getting anything out of it because it's not giving you any price appreciation. So if you're looking to get into a stock, at least look at a stock chart to see which way the stock is moving. Now, Clorox has sort of entered this sideways channel. It had the nice move down and now it's moving sideways. So maybe it's found a bottom here. Maybe they figured, the market's figured $160 a share is the bottom for Clorox. It's not going any lower. It's tried a couple of times to get through 160, not happening. So maybe the next move here is to move back to the top of the channel and maybe eventually get out of the channel and at least above the 200-day moving average. So I know Clorox is a great company, but I wouldn't buy in yet because it's not showing me it's time to buy in yet. When will that happen? When would I feel good about buying in? If I was to buy Clorox, I'd have to see it move out of the channel and probably above the downtrending 200-day moving average. So somewhere between $185 and $190 a share is probably when I would consider, okay, it's safe to get into Clorox. It's got new upwards momentum and that should keep going. Yeah, I may miss buying at the bottom, but I'll be buying at a time when it's got the momentum behind it. But if you're really itching to get in, then I always say you could nibble. You can buy a few shares, buy a handful of shares.  Buy a little down here and then if you're right, you can say, yep, I bought the bottom. And if not, then you wait for confirmation. All right, so that's some of the things we look for. Downtrending stock, even though it may be a great company, you want to time it a little better and wait for it to show you some upwards momentum. Let's take a look at my list here, see what other stocks we have. Microsoft, still looking pretty good. You know, it was in this channel. We drew the channel way back here, went above the channel and it's had a little pullback with the general market, but still pretty strong Intel. Intel just not doing much for me. I wouldn't really do anything with Intel. It just kind of has them downwards momentum, trying to move, been moving sideways here. So maybe it's sort of finding a bottom. You can see a little bit of a rounded bottom potential. Maybe we'll start to move higher. But for me right now, I'm just keeping an eye on Intel. It's not telling me that it's really time to get a full on bullish position yet. So I'm just watching the price action. And for Intel, not so convinced that it's time yet. Let's see what else we have. Oh yeah, AMD we always look at. We look at AMD. So AMD, so I had some W patterns, some channels, a bigger channel. All these things that you can draw on your chart to help you gauge when it may be time to get in and or get out. We can see here, so let's take these lines off. And it's okay to remove old lines. I mean, stocks move in different directions all the time. We can see we had support here. So it looks like AMD's got pretty solid support right around the 100 level. Okay, you can draw a line here. All right, so it has support. It tried to break down below 100, one, two, three, four, almost four times it tried to break below it. Couldn't get it. It was rebuffed each time. So we're hoping that AMD will continue to move higher. It's got a little bit of a down look to it. We can also draw sort of the triangle here. Typically this would be a bearish position where a bearish pattern where it keeps moving down along the top line here and eventually it'll pop through support but it's got good support here. So I'm waiting to see what's gonna happen. AMD might tick a little bit tighter in this end of the triangle here and then pop above it or pop below. So I'm holding out here. Now the next round of earnings is happening pretty soon. Earnings is gonna get underway starting next week and for the next few weeks we're gonna have lots of companies putting out earnings. So I don't really like to get into position before the earnings announcement. So especially with AMD I think it announces earnings towards the end of October, maybe the third week of October. So I may just sit and watch, see what AMD does if it fulfill the rest of this triangle here and start to move up or move down and nothing may not happen until it's earnings announcement. So it may just be storing up this energy until earnings comes out. So that's AMD. We had a position on it and we took profits on it and now we got out. Let's see what else we have. We looked at Netflix. Netflix is doing pretty good. Been bucking the trend was in this channel for a long period of time, finally moved above it was hugging the 20 day moving average and has blasted off. So we have all time new highs. Let's just make sure that's right. Yep, all time new highs for Netflix. Netflix is strong. Netflix looks good. If you're trying to time your next bullish entry at this point you may wanna see if it pulls back to the 20 day moving average if you're trying to time a bullish trade Netflix looks pretty good as a bullish contender. Procter and Gamble, Walmart. Let's take a quick look at Walmart because I personally got into some Walmart down near the lows last week. I was just too much of a pullback for me not to get in. Now I say, why would I want to get long a stock when it's in a downtrend? Well, sometimes I go outside of my own rules, gut reaction, but the main reason why is because the RSI got into extremely oversold levels. Hit down in the 20s here, 20 on the RSI. That was my cue that, you know what? Walmart's a great company. If I wanna hold Walmart for the long run, I'm holding for the long run. And every once in a while pullbacks are just too extreme and you could nibble. And that's what I did. I nibbled, I bought some shares on the lows here and look, it's popped back. Okay, got in around down here, 136, 137 or so and now it's around just under 140. So it's moving back up. Walmart could certainly continue to move back down, but for me, I was taking a calculated risk. I bought some shares, but I know in the long run, Walmart will go back over time. For now I may have to sit and wait a little bit, but that was a personal decision that I made. What else do we have? Disney, everyone loves Disney, right? Hard not to love Disney, but right now it's in this channel. Was in the up trend, down trend, sideways trend. That's how stocks move. They go up, down, sideways. So Disney's sort of in the sideways action here. If it can get above, I don't know, maybe 185 or so it may have the momentum to keep moving higher. You got the seasonality of the end of the year coming. So we may see a lot of stocks start to move higher. So Disney's sort of in this channel here. I would probably wait till it starts to move up maybe in the 185, 190 level to see if I wanted to or when I would want to get long some of those shares. What else we got? So the pharmaceutical stocks are getting hit pretty good. We've taken a position in Bristol Myers, a put-sell position, had a lot of cushion right here. Also was way oversold. That was around $60 a share. We sold some put options, strike prices down here. We gave ourselves a lot of cushion. Stocks still moving down. Friday, yesterday had a big move down. I'm not really sure what that was all about. Getting back down into the oversold territory again. This is an extreme move for a company like Bristol Myers. This is Bristol Myers. We took a stab on a put-sell. We may have to roll the trade and invoke some defense mechanism, but not yet. So we're watching, waiting. Eli Lilly, let's just look at some of these healthcare stocks. Eli Lilly's in a down move. Pfizer, Pfizer in a down move. Johnson and Johnson. All these pharmaceuticals are in the downtrend. Kind of hovering around the oversold areas. Eventually these are gonna be buys. Eventually all these stocks will be buys. Now Merck had came out with the news that they have a pill that is like the COVID vaccine but in a pill format. So that's why Merck jumped big this past week. So Merck's bucking the trend of the rest of the pharmaceuticals. But in general, pharmaceutical companies will be bought back up. Just, it's the timing, when is it gonna happen? So keep an eye on those. We're keeping an eye on Bristol Myers as we have a position there. Facebook. We had a spread position in Facebook that we got out of. I didn't like the move down. I didn't like the news headlines that were coming out of Facebook the last week or so. Plus they have outages. I said it's time to get out. Sometimes you're wrong. Not every position's going to work out. We got out of Facebook. So it was in this downtrend. Probably gonna find support here at the 200 day moving average. But Facebook right now, I've got nothing on Facebook. I don't like the down move. I don't like the news out coming out of the company right now. So there's nothing for us on Facebook. Google always looking strong. Google just keeps going up. What else do we have? It's about it for our individual stocks, the ones we like to look at. Costco is always a strong stock. Got some sideways action. McDonald's. Let's take a closer look at McDonald's. McDonald's looks good. Was in the sideways action. Has a nice rounded, nice upwards moving stock. All the moving averages are sloping upwards. The RSI is right in the middle. So it's not overbought, not oversold. So McDonald's has some good momentum behind it. If you're looking to get long, and maybe see if it pulls back to the 20 day or 50 day as a timing mechanism. But in the long run, McDonald's is moving up strong stock. All right, so quickly one more time. SPY. For me, I need to see some more bullish action outside of the downtrending channel. And like to see it start to move up. So I'm gonna be a little bit more of a wait and see attitude. We've got earnings coming up in the next few weeks. So it could be a little hands off for now. All right, so that's what I'm seeing in the market. That's it. I hope this is helpful for you all to see how you can look at stocks, draw patterns, check your moving averages. Just watch the price action. It'll help you quite a bit. All right, let's take a quick look at our website here. Smart options seller website. We're big put option sellers here. If you want a free copy, if you know nothing about selling put options, just download our free guide. Go to our website, click on the put selling basics. This is a guide that I wrote. Put your name and email address here. We'll send you a free copy. Here's our services tab. You can click on any of these things. Anything, all this other free stuff is to help you all. Give you some good options information. Our paid services right here, we have two newsletters and our coaching sessions if you need a little help, okay? So I hope this video has been helpful. Give me a thumbs up, leave me a comment. If you would, I love hearing from you. Send me an email. I'll always answer your emails and don't forget to subscribe to this channel. Hit that red subscribe button in the bottom right hand corner of this video. All right, that's all for me today. We're getting on close to 35 minutes now. I hope everyone has a great weekend and a great trading week ahead. I hope to see you back here next Saturday. This is Lee Lowell signing off.


It is a half-day centered on the trans and non-binary communities. It's a chance for us to come together and share our experience working on a common problem, to build community and feel a little bit less alone. So transcode is tremendously important because it gives us a space to be among those that are like us, which in my case is very rare. So I really appreciate the opportunity to meet all those wonderful trans people that are here. And I think it's also important because it gives us space where other people who are not quite ready to come out to see that there is a safe space for them so that they will maybe eventually take the next step and come out and be part of this wonderful community that is a trans community. Something I really loved about today is meeting people of different ages, different life stages. And in my personal life I've got a lot of trans friends and family, but we're in a little bit of a bubble. And just being able to geek out about shared interests, having a shared sense of humour with people I've never met is really, really lovely and of course getting to nerd out about code.


Well, I'm delighted to be here today and the reason you haven't heard about this very much before, if at all, is because this is a new system and it just got launched in November. We had done six months of solid testing. We had worked with Dr. Hegman, but it's just being rolled out and of course with the holidays and everything else is catching up now, getting a lot of steam. We are teaching all of the medical students to use this as part of one of their third year rotations. And Speed was in one of the first cohorts of us teaching it to the medical students and he's really a huge proponent and we have other folks who are also huge proponents as we go farther. The farther system stands for Federated Utah Research and Translational Health Electronic Repository and its purpose is to support clinical and translational research. It joins data from multiple sources. It is for retrospective study, although people are saying they could use it in prospective studies. For example, when they have a clinical trial going, they can look on an ongoing basis to see how many more patients have come in that I could then contact to enroll in my clinical trial. So it's got a lot more capability depending upon your curiosity and your ability to search it. And we also have ongoing work that's happening as we all being done under my hat, not as department chair in biomedical informatics, which is a department in the school medicine. But in my associate vice president hat, where Dr. Betts asked me about four years ago, would I please take on this role and work to, as one of my very top priorities, make clinical data accessible to the research community. So this is actually a lot of hard work under the hood to make all of this match up and make sure we're querying the right sources and it matches up with the electronic medical record folks and the new PDB. But it's a fairly simple front end. It doesn't do everything you want. It gets you started and I think that's the big thing. So the current state is this aggregate count across data sources for pre-research questions and unique in common patients across these data sources. It is new, as I said, and really the reason that you do cohort searching, as Barbara was saying, is that it's the way you start saying, do I have a big enough patient population that will manage my clinic? Actually, there have been studies which show that about 60% of clinical trials, enough patients to complete what they anticipated would be an adequate patient number to finish their study. And we did a study here at the University of Utah, looking over five years of past retrospective data at the IRB, and 75% of the studies here were either delayed or did not fulfill their requirements for getting enough patients in their cohort. Some portion of that is because people have not had access to figuring out what are the right criteria to ask for. So we did this originally because of the CTSA, Clinical and Translational Science Awards. There's a large national award. We have one here at the University of Utah. There are about 16 medical schools who have them. And that award sits in the middle of our Center for Clinical and Translational Studies. And part of this, we envisioned being able to search not only University of Utah hospitals and clinics patients, but also Huntsman Cancer Institute patients, Intermountain Healthcare, VA. This is the Utah Department of Health and other partners as we go forward. And saying we have such data resources here in the Utah area, let's search across all of them. And we are in the process of doing that. And across more than just clinical data, but also genotypes, phenotypes, public health data, and pedigree data. And we probably have more of all of this combined in Utah than anywhere else in the United States. But it's hard to get access to. So right at the moment, we have two data sources that you can search from your desktop, and I'll show you some of these today. So first of all, it's the Electronic Data Warehouse, which sits at the University of Utah. We have data back to 1994, 1.5 million patients, lab results, medical orders, diagnoses, and procedures. And so when you search, you're searching across all of these records of 1.5 million patients. And then sometime in the month of March, we're adding encounters. And because of all of the new epic systems, we're bringing in all the clinic data in the encounter. So there will be a whole host of new things. So it changes all the time and will be bigger. And then we're searching across the UPDB Limited database. That's the Utah Population Database. That's got 6.5 million individuals. Goes into hospital claims data across the state, 96 to present, gets you into cause of death. These sit in the Vital Statistics Registry at the State of Utah in their Department of Health. First certificate's pedigree quality, and has a master subject index that they've developed in that group over the years, which is pretty amazing. As they link all of these records together, you want to know are these unique patients, do these records belong to the same patient, or are these different patients? So they've worked pretty hard to develop that. And we use that in our further as searching across these sources to say who is a unique patient and which ones are duplicative. Right now, we use it particularly across the University and Intermountain to help make sure we know which is a unique patient. And we're working to bring Intermountain live, but it's not live yet. So what happens? You can get online. Is anybody in here search the UPDBL on person? Two people. I think that it's a very useful resource. And if you're especially, you're looking at these data sources and only these data sources, then I certainly recommend you get on there and it's very useful for cohort finding. But what further does is search all of the UPDBL and the EDW data on top of that, gets you cohort statistics, and then it does not right now get you record level patient data. It may or may not in the future. And the reason it may or may not is because the IRB is watching us pretty closely and making sure what we're doing is totally HIPAA compliant and in line with regulations. So right now what you have to do is to take these patient accounts that you see, and when you finally fiddle with all of these parameters to say these are inclusion-exclusion criterias for my cohort, then I'm going to take it, I'm going to write an IRB, I will get permission to do it, and then you pull that data and right now you have to go back to the UPDBL and the EDW to jointly pull that data, get yourself a set of data and work with it from that point on because at that point it's identified and IRB has approved it. The environment is, we use a system that I'll show you the query tool, the front end query tool, it's called I2B2. It's a query tool which has been developed by Harvard, they have a national center for biomedical computing assistant for the country, and they've developed this front end query tool which is pretty zippy, actually it doesn't do everything you want but that's where we're starting. As I said, we have two data sources, we federate by patient ID, aggregate queries, some union and intersection and these data types. So here's what it looks like, and I put the URL right up there so you can get online at any time you want to, and you start over here and it says register for an account, and that's the very first thing you do and anybody who has a UID can register for an account. You have to wait after you register to get an email back saying we confirm your registration so it doesn't take too long but you can't just immediately jump in, you have to wait a little while to get an email confirmation and then you can start querying, and I will do some querying in just a moment, but I have to tell you once you pull it up, you need to read this data use agreement. The data use agreement is IRB has said please make sure this is on there and you can't get an account until you agree that you'll do it. Now it's kind of like all the time on my laptop I'm always downloading things and saying I agree, I agree, I agree, but this is pretty important that the information I have provided is really you doing the searches, and they want you to use this data to provide information for proposals or project development preparatory to conducting your research. So it's not meant to be frivolous, but it is a pre-research tool. The biggest thing is I will not attempt to identify any individual represented in the query system, and we have gone through all kinds of statistical rules and regulations to make sure that what you see are large numbers. You'll see asterisks in various places, and that means if you choose, if you have a cell which is five or fewer, it won't tell you it's five or fewer gives you an asterisk because they feel like if you do a series of queries you can start identifying people, and IRB and our regulation folks don't like that at all. So I'm going to get online here and I'm going to do diabetic cataract. I talked to Barb ahead of time and she gave me some clues as to what might make sense, so I've done several of them. This is where you do your query, and this is how you find your terms. You also have a list of previous queries and a workplace where you can save everything you do. The previous queries will save for maybe a week or two, but you'll lose them. If you want to save them, you have to drag them up and save them. I'm going to do it by finding terms, and this is simply something which says search by names and this contains. Now you could do other than contains, but this is pretty good. There's diabetic cataract. It is searching now by ICD-9 codes, and you can take that and drag it over here. You could do more queries, so this is if you put more and more in here, it would be diabetic cataract or macular degeneration or something, you could look for all of those. If you do it across these groups, it's AND, but I'm just going to run this query with the single source, and I say I'm going to say tell me who is in the Enterprise Data Warehouse or the UPDB Limited with those who has diabetic cataract. Now it's in, so it doesn't fit all on one screen as well as it did before, but maybe it does on that one. Down here it's executing the query, and it'll tell you how many seconds, and I do have to say that you have to be careful when you do this. Sometimes you'll launch a query which takes a long time. This is not a system which is like when you're using APRIC or CERNR, and you're not seeing patients when you do this.  You're not in a patient care situation. I'm contemplating my research situation. While it's doing that, I want to show you some other things that are to move my screen around. I have a help screen which will give you a sense of assistance introducing it, but the help videos I think are quite useful. I would start there, overview or how you select terms or building a query, and I think that they're really quite useful for helping you get started. This tells you about the analysis tools. I'll show you how to do that in just a moment, how you use previous queries in your workplace. It definitely says that ITB2 comes from Harvard Medical School, but we did some modifications and we're using it here. This is the only one I'm really going to run live. I have some saved ones so that you can see them a little bit better and blow them up. Down here, it has executed your query. It took 120 seconds to do that, so it took two minutes. It searched across six and a half million records in all of the ICD codes. It found that you've got 1223 patients and that most of them are in the EDW. You've got diabetic cataract in that many patients, and you have to say, is that enough to do a study or not? It's a pretty big number. It only found 34 of them in the UPDB, and there's nine patients in common between the two, so unique patients. There's 1248. Let me show you how you could say tell me a little bit more about those patients. It says load a plug-in, but we only have one plug-in, and it's a demographics plug-in right now. First of all, I decided to compare diabetic cataract. We found 1,020. Wait a minute. Well, I don't know what it was. Anyway, we found some. But if, in fact, instead of that, you were going to do diabetes and cataract together, so you could search diabetes, mellitus, and cataract, then what you find is 10,000. The suggestion if you were going to do a study is that not only would you want to find those people who with a definite diagnosis of diabetic cataract, but you would also want to look at that other group in order to see maybe there were some with diabetic cataract who weren't actually given that specific diagnosis, but they've got both of those diagnosis together, and maybe you've got a larger group than you saw before. So what you see over here is that all I did was to choose cataract. I chose the entire group of cataracts, 366, drug it over there, and did this particular query. And then you can see how many unique patients you have along the way and how many patients in common, which is coded over here. So you could add that to your query list, and you can, if in fact you have a new group, you could keep adding things to your query list. So it doesn't just have to be three, it could be five, six, or seven, and you can search for other things as well, and I've got some examples of that. I think what I did was to load your, well, here's a glaucoma example that goes on for several of them. So I chose glaucoma over here, queried that, and then I added to that with how many do you have with organic sleep apnea and glaucoma. And what you find here is that you've got 160 patients in the UPDB, 465 in the EDW, unique patients, you've got 605 of them. Now submitting that and then going forward, I added some more things to it. I said, there's other kinds of sleep apnea, unspecified sleep apnea, hypersomnia with sleep apnea, insomnia with sleep apnea. So you can find other diagnoses to add, and then you can ask it in age categories. In this particular case I said between the ages of 30 and 89, those are demographics age categories. And it took longer to run, but what you found is 308 here, well, 308 in the UPDBL, 806 here in the data warehouse, and 1075 patients overall. Now if you got your, if the demographic plug-in had worked, this is kind of what you would see. So it, first of all, looks at how many, what are your patients, some total, unique patients, patients common to all sources in this particular query. So that was the glaucoma and sleep apnea query. Two sources responded to that, et cetera. And here's your age distribution. You do have some younger patients going back to 35 with that. And it will also tell you the pedigree quality. This is, of course, being pulled from the UPDB. So if you're wanting to say, does this run across generations, you've got 109 multi-generators and pedigrees that have that in there, and you can certainly use that to think about this a little bit more. It also, I mean, there is missing data along the way. And then here's an other, and you'll see the asterisk which says it's five or less in the other category, and therefore you can't answer it. It tells you race, religion, male, female, deceased. Let me go back up and say, deceased comes from the vital records, vital status deceased. So that comes from the state vital records. And then this looks at patients in common over all data sources. So that's the UPDB and the EDW both, and gives you once again the data related to that. Now, in this particular case, unless you're interested in those pedigree data, then I would suggest that you just go to the EDW and find it because you're not going to find that much in UPDB. Here's another one, seen on macular degeneration and antihyperlipidemic drugs. Barbara said, how about statins? And what I decided to do was two queries, one of which was looking at the drug. So I was over here looking at medication orders, pulled antihyperlipidemic agents, and this gave me 1067 patients. But I want you to note particularly, it says negative one in UPDB. And negative one is our symbol, which says, I can't find anything because I can't search this data source. UPDB doesn't have medications, it doesn't have drugs. So it simply says, if you want a query to find this kind of patients in the UPDB L, you can't search it this way, you'll have to search it and not have drugs come up. But then I decided I would compare, if you just looked at statins, how many you'd find. So it found, well, let me go back to this one. With antihyperlipidemic, it found 1067 patients. And if you look at searching it with just statins, here's your breakdown of within the antihyperlipidemic agents, you've got a bunch of them which come in along the way, all of these different kinds. And here's all your statins, HMG, CoA reductase inhibitors, and you find 115. So for most of the patients who are on antihyperlipidemic drugs, most of them are on statins. And you find 1,015 patients. Once again you can say, what's the age range? Barbara was saying you think that there might be a protective effect to statins, and this tells you how many patients you would have, and then you would have to figure out what to compare it to. This doesn't do your whole experiment with you, for you. It says now let me think about what do I compare it to, to see if the incidence is higher or lower. And I think I've almost run out of time, got two minutes. But this is what you do next, register for an account, start querying, check out the help videos, email for assistance further at utah.emu, send me comments and use it. It really can help you with your research. And it'll grow as we go forward. So thank you very much. We are working on specific electronic communication with the IRB, but that isn't here yet. That'll come soon, I don't know about soon. It'll come several months probably. The IRB, what you can do is to print out those further screens and you can talk specifically about your query. And when you queried the EDW and the UPDBL you found the following cohort numbers and then write your IRB around it. And then you have to get both IRB and RGE approval, RGE if you want any data coming from UPDBL. And then that has to be pulled for you by the EDW team or UPDBL team. We hope in the future the IRB will be comfortable with our system pulling the data once we hear that you've got an IRB, but that's not here yet either. The IRBs are just taking it as slow and we're still developing the system. So what we've had people say is it cuts about three months off the front end of their cohort development cycle to figure all of this stuff out at their desk nights, weekends, and get their research assistance also working with it along the way. If you're just searching EDW then you don't, EDW team, and pull data from them.


Hi and welcome to the session, I'm Asha and I'm going to help you with the following question which says show that if A is a subset of B then C minus B is a subset of C minus A. So first let us learn some simple ideas. First is A is a subset of B which is denoted by S sign if every element of set A is an element of set B and second is A minus B is the difference of set and it contains all those X such that X belong to A and not to B. So with the help of these two definitions we are going to solve the above problem. So this is the idea. Now proceed on with the solution and we are given that A is a subset of B. Let X be any arbitrary element such that it do not belong to set B then this implies X do not belong to set A does this because A is a subset of B and the elements which are not in set B cannot be set A also. Now let us take any arbitrary element which belong to set C minus B this implies that Y belong to set C and Y do not belong to set B this is by the definitions of different set. Now Y do not belong to set B implies Y do not belong to set A also this is from this point this implies Y belong to C and Y do not belong to A this is from here this implies that Y belong to C minus A. So this implies all elements which belong to set C minus B also belong to C minus A and hence the set C minus B is contained in the set C minus A is a subset of B. So this completes the solution hope you enjoyed it take care and have a good day.